Xiaofan Liu

机构：Capital University, Capital Medical University · ORCID：0009-0004-3990-1030

发表论文 134 篇 · 总被引 2003 次 · h-index 17

代表论文

• Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study (2024 · The Lancet Haematology · 被引 29)
• Proteomics landscape and machine learning prediction of long‐term response to splenectomy in primary immune thrombocytopenia (2024 · British Journal of Haematology · 被引 9)
• Associated transcriptional, brain and clinical variations in schizophrenia (2024 · Nature Mental Health · 被引 8)
• Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial (2024 · Annals of Hematology · 被引 7)
• Automated detection of radiolucent foreign body aspiration on chest CT using deep learning (2025 · npj Digital Medicine · 被引 5)
• The long‐term intake of milk fat does not significantly increase the blood lipid burden in normal and high‐fat diet‐fed mice (2024 · iMeta · 被引 3)